Morse Elliot, Fujiwara Rance J T, Judson Benjamin, Prasad Manju L, Mehra Saral
Department of Surgery, Division of Otolaryngology, Yale University School of Medicine, New Haven, Connecticut.
Yale Cancer Center, New Haven, Connecticut.
Laryngoscope. 2019 Jan;129(1):129-137. doi: 10.1002/lary.27221. Epub 2018 Sep 7.
OBJECTIVES/HYPOTHESIS: To establish benchmarks for positive margin incidence in parotid cancers, associate positive margin status with patient, tumor, and institutional factors and overall survival, and characterize institutional variation in positive margin incidence.
Retrospective database analysis.
We identified patients surgically treated for a parotid malignancy 2004 to 2013 in the National Cancer Database. We associated positive margins with patient, tumor, and treatment factors by multivariable logistic regression and with overall survival by Cox proportional hazards regression. We characterized institutional variation in positive margin rates by facility type and volume.
A total of 5,639 patients were identified. The overall positive margin rate was 31%. By institution, positive margin rates varied from 0% to 100%, with a median rate of 31% (interquartile range = 18%-43%). Adenoid cystic carcinoma was associated with increased, and low-grade mucoepidermoid carcinoma with decreased, odds of positive margins, (odds ratio [OR] = 1.91 [95% confidence interval {CI}: 1.54-2.38], P < .001 and OR = 0.68 [95% CI: 0.53-0.87], P = .002, respectively). Treatment at academic or high-volume facilities was associated with decreased odds of positive margins (OR = 0.79 [95% CI: 0.68-0.91], P = .001 and OR = 0.76 [95% CI: 0.63-0.91], P = .004). Positive surgical margins were associated with decreased overall survival (62% vs. 79% 5-year overall survival, hazard ratio [HR] = 1.34 [95% CI: 1.20-1.49], P < .001). Upon stratification by histology, this association was maintained for high-grade, but not low-grade, mucoepidermoid carcinoma (52% vs. 74%, HR = 1.56 [95% CI: 1.31-1.86], P < .001 and 89% versus 91%, HR = 1.05 [95% CI: 0.60-1.83], P = .874, respectively).
Tumor and institutional factors are associated with positive surgical margins. Positive margin rates vary substantially between facilities and are less likely at academic and high-volume facilities. Positive surgical margins are associated with decreased overall survival and could be considered quality indicators in parotid malignancies.
2c Laryngoscope, 129:129-137, 2019.
目的/假设:建立腮腺癌切缘阳性发生率的基准,将切缘阳性状态与患者、肿瘤及机构因素和总生存率相关联,并描述切缘阳性发生率的机构差异。
回顾性数据库分析。
我们在国家癌症数据库中识别出2004年至2013年接受腮腺恶性肿瘤手术治疗的患者。通过多变量逻辑回归将切缘阳性与患者、肿瘤及治疗因素相关联,并通过Cox比例风险回归将其与总生存率相关联。我们根据机构类型和手术量描述切缘阳性率的机构差异。
共识别出5639例患者。总体切缘阳性率为31%。不同机构的切缘阳性率从0%到100%不等,中位率为31%(四分位间距=18%-43%)。腺样囊性癌与切缘阳性几率增加相关,而低级别黏液表皮样癌与切缘阳性几率降低相关(优势比[OR]=1.91[95%置信区间{CI}:1.54-2.38],P<.001;OR=0.68[95%CI:0.53-0.87],P=.002)。在学术机构或手术量大的机构接受治疗与切缘阳性几率降低相关(OR=0.79[95%CI:0.68-0.91],P=.001;OR=0.76[95%CI:0.63-0.91],P=.004)。手术切缘阳性与总生存率降低相关(5年总生存率分别为62%和79%,风险比[HR]=1.34[95%CI:1.20-1.49],P<.001)。按组织学分层后,高级别黏液表皮样癌仍存在这种关联,但低级别黏液表皮样癌不存在(分别为52%对74%,HR=1.56[95%CI:1.31-1.86],P<.001;89%对91%,HR=1.05[95%CI:0.60-1.83],P=.874)。
肿瘤和机构因素与手术切缘阳性相关。不同机构间切缘阳性率差异很大,在学术机构和手术量大的机构中切缘阳性的可能性较小。手术切缘阳性与总生存率降低相关,可被视为腮腺恶性肿瘤的质量指标。
2c 《喉镜》,2019年第129卷,第129 - 137页